1. Home
  2. LXEO vs PHD Comparison

LXEO vs PHD Comparison

Compare LXEO & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • PHD
  • Stock Information
  • Founded
  • LXEO 2017
  • PHD 2004
  • Country
  • LXEO United States
  • PHD United States
  • Employees
  • LXEO N/A
  • PHD N/A
  • Industry
  • LXEO
  • PHD Investment Managers
  • Sector
  • LXEO
  • PHD Finance
  • Exchange
  • LXEO Nasdaq
  • PHD Nasdaq
  • Market Cap
  • LXEO 140.6M
  • PHD 117.7M
  • IPO Year
  • LXEO 2023
  • PHD N/A
  • Fundamental
  • Price
  • LXEO $2.71
  • PHD $9.05
  • Analyst Decision
  • LXEO Strong Buy
  • PHD
  • Analyst Count
  • LXEO 5
  • PHD 0
  • Target Price
  • LXEO $22.20
  • PHD N/A
  • AVG Volume (30 Days)
  • LXEO 1.4M
  • PHD 67.7K
  • Earning Date
  • LXEO 05-08-2025
  • PHD 01-01-0001
  • Dividend Yield
  • LXEO N/A
  • PHD 11.43%
  • EPS Growth
  • LXEO N/A
  • PHD N/A
  • EPS
  • LXEO N/A
  • PHD 1.27
  • Revenue
  • LXEO N/A
  • PHD N/A
  • Revenue This Year
  • LXEO N/A
  • PHD N/A
  • Revenue Next Year
  • LXEO N/A
  • PHD N/A
  • P/E Ratio
  • LXEO N/A
  • PHD $7.60
  • Revenue Growth
  • LXEO N/A
  • PHD N/A
  • 52 Week Low
  • LXEO $1.45
  • PHD $8.30
  • 52 Week High
  • LXEO $19.50
  • PHD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 48.48
  • PHD 42.49
  • Support Level
  • LXEO $1.90
  • PHD $8.84
  • Resistance Level
  • LXEO $2.64
  • PHD $9.20
  • Average True Range (ATR)
  • LXEO 0.48
  • PHD 0.23
  • MACD
  • LXEO 0.02
  • PHD 0.00
  • Stochastic Oscillator
  • LXEO 51.43
  • PHD 64.52

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About PHD Pioneer Floating Rate Fund Inc.

Pioneer Floating Rate Trust is a diversified, closed-end fund. Its investment objective is to provide a high level of current income and seek the preservation of capital by investing predominantly in floating-rate loans.

Share on Social Networks: